Loading
NYSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$11.31
−$0.01 · -0.09%
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Previous close
$11.31
−$0.01 · -0.09%
Pre-market
$11.22
−$0.09 · -0.80%
Sep 14, 8:29 AM ET
Regular session · ET · Market data may be delayed.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $11.31
52-week range
Current $11.31
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
61
Undervalued
Sentiment
53
Mixed
Risk
67
High Risk
Momentum
57
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.
Day range
Current $11.31
52-week range
Current $11.31
| Metric (USD) | FY2025 |
|---|---|
| Revenue | 1.18B USD |
| Cost of goods sold | 470.01M USD |
| Gross profit | 711.17M USD |
| Selling, general, and administrative | 445.21M USD |
| Operating expenses | 562.85M USD |
| Interest income | 14.52M USD |
| Interest expense | 63.45M USD |
| Depreciation and amortization | 173.4M USD |
| Operating income | 148.32M USD |
| Net income | −116.38M USD |
Company facts updated Sep 14, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$15.00
32.63% upsideFunds reporting this stock among their holdings, ordered by reported position size.
AdvisorShares Pure US Cannabis ETFMSOS
Amplify Seymour Cannabis ETFCNBS
AdvisorShares Pure Cannabis ETFYOLO
Hedgeye 130/30 Equity ETFHELSAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
